Pico Smokerlyzer, Model EC-50

The Pico Smokerlyzer, Model EC-50, is primarily used in clinical and advisory settings, particularly within anesthesiology. Its relevance stems from its ability to measure exhaled carbon monoxide (CO) levels, a byproduct of tobacco smoke, helping assess a patient’s smoking status. This information can be critical for anesthesiologists to tailor pre-operative care, manage risks associated with smoking, or inform patient counseling during consultations.

The Pico Smokerlyzer is designed as a reusable analyzer, meaning it is built for repeated use in clinical environments. Since it is not sterile by design, maintenance involves regular cleaning and calibration as outlined in the manufacturer’s technical documentation to ensure accurate CO measurements over time. Reusability also implies the need for proper storage to prevent contamination or damage between uses.

The Pico Smokerlyzer follows FDA 510(k) clearance (K000962) and MDR compliance, confirming it meets regulatory standards for Class II devices. This means it has undergone rigorous review by the FDA’s Anesthesiology Advisory Committee (AN) to demonstrate substantial equivalence to a predicate device. Clinicians can rely on its compliance for clinical use, though they should always follow local guidelines and manufacturer instructions for proper operation.

Unlike some single-use or disposable carbon monoxide analyzers, the Pico Smokerlyzer is explicitly reusable and designed for clinical or advisory settings, particularly in anesthesiology. Its primary purpose is to quantify exhaled CO levels as a diagnostic tool for assessing smoking status, rather than for general environmental monitoring or industrial applications. This distinction ensures its use is focused on patient-specific evaluations in controlled medical environments.